VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

BOPA/ISOPP 2019 | Choosing cancer clinical trial endpoints

Bruce Burnett, Swansea University, Swansea, UK, highlights the important considerations when choosing cancer clinical trial endpoints. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter